DOD BIOTECH PUBLIC COMPANY LIMITEDSET: DOD🇹🇭 TH
This company's most recent 56-1 One Report was filed as a PDF document (spec v3.0), so SET does not publish its section-by-section detail in a machine-readable form. Some information on this site is therefore incomplete.

News & Press Releases

SET Announcements

18 Nov 2026

Notification convening date of the Public Presentation

Read the full announcement on the SET website ↗
12 Nov 2026

Progress Report on Events or Indications Affecting Internal Control System. (Revised)

Read the full announcement on the SET website ↗
11 Nov 2026

Financial Performance Quarter 3 (F45) (Reviewed)

Read the full announcement on the SET website ↗
11 Nov 2026

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2026

Read the full announcement on the SET website ↗
11 Nov 2026

Progress Report on Events or Indications Affecting Internal Control System.

Read the full announcement on the SET website ↗
11 Nov 2026

Financial Statement Quarter 3/2026 (Reviewed)

Read the full announcement on the SET website ↗
14 Oct 2026

Clarification on the Revisions of the Financial Statements for the First Quarter of 2026 (Further Revised) and the Second Quarter of 2026 (Revised)

Read the full announcement on the SET website ↗
14 Oct 2026

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026 (Revised)-Revised Auditor's Report

DOD BIOTECH PUBLIC COMPANY LIMITED submitted a revised auditor's report for its Management Discussion and Analysis for the first quarter ending 31 March 2026. The revised report covers the company's performance for the period.

Summarised automatically from the announcement filed with SET.

Read the full announcement on the SET website ↗
14 Oct 2026

Financial Performance Quarter 1 (F45) (Reviewed)(Revised Auditor's Report)

DOD Biotech reported a loss of 21,874 thousand baht for the first quarter ending 31 March 2026, compared to a profit of 27,204 thousand baht in the same period last year. Loss per share was (0.049) baht, versus earnings per share of 0.06 baht. The auditor’s report contains a qualified opinion with an emphasis of matters.

Summarised automatically from the announcement filed with SET.

Read the full announcement on the SET website ↗
14 Oct 2026

Financial Statement Quarter 1/2026 (Reviewed) (Revised Auditor's Report))

Read the full announcement on the SET website ↗
14 Oct 2026

Management Discussion and Analysis Quarter 2 Ending 30 Jun 2026 (Revised)

DOD Biotech Public Company Limited reported its Management Discussion and Analysis for the second quarter ending June 30, 2026. The announcement has been revised.

Summarised automatically from the announcement filed with SET.

Read the full announcement on the SET website ↗
14 Oct 2026

Financial Performance Quarter 2 (F45) (Reviewed) (Revised)

DOD Biotech reported a qualified opinion on its reviewed financial statements for the second quarter and six months ended June 30, 2026. Profit attributable to equity holders was 941 thousand baht for Q2 2026, compared to 9,582 thousand baht in the same period last year. For the six-month period, the company reported a loss of 20,933 thousand baht, versus a profit of 36,786 thousand baht in 2025. Earnings per share were 0.002 baht for Q2 and (0.046) baht for the six months.

Summarised automatically from the announcement filed with SET.

Read the full announcement on the SET website ↗
14 Oct 2026

Events or Indications Affecting Internal Control System. (Revised)

Read the full announcement on the SET website ↗
14 Oct 2026

Financial Statement Quarter 2/2026 (Reviewed)(Reissue) (Revised)

Read the full announcement on the SET website ↗
24 Aug 2026

Report of the Public Presentation

Read the full announcement on the SET website ↗
17 Aug 2026

Notification convening date of the Public Presentation

Read the full announcement on the SET website ↗
13 Aug 2026

Clarification on the Revision of the Interim Financial Statements for the First Quarter of 2026 (Reissued)

Read the full announcement on the SET website ↗
13 Aug 2026

Events or Indications Affecting Internal Control System.

Read the full announcement on the SET website ↗
13 Aug 2026

Financial Performance Quarter 2 (F45) (Reviewed)

Read the full announcement on the SET website ↗
13 Aug 2026

Management Discussion and Analysis Quarter 2 Ending 30 Jun 2026

Read the full announcement on the SET website ↗
13 Aug 2026

Financial Statement Quarter 2/2026 (Reviewed)

Read the full announcement on the SET website ↗
13 Aug 2026

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026 (Revised)-Revised Auditor's Report

Read the full announcement on the SET website ↗
13 Aug 2026

Financial Performance Quarter 1 (F45) (Reviewed)(Revised Auditor's Report)

Read the full announcement on the SET website ↗
13 Aug 2026

Financial Statement Quarter 1/2026 (Reviewed) (Revised Auditor's Report))

Read the full announcement on the SET website ↗
31 Jul 2026

Progress Report on the Payment of Deposits and Advances Totaling 141 Million Baht

Read the full announcement on the SET website ↗
19 Jul 2026

Notification of the SEC Office's Approval to Extend the Deadline for Submission of the Amended Financial Statements for the First Quarter of 2026

Read the full announcement on the SET website ↗
14 Jul 2026

Report of the Public Presentation

Read the full announcement on the SET website ↗
6 Jul 2026

Notification convening date of the Public Presentation

Read the full announcement on the SET website ↗
11 Jun 2026

Clarification on the 70% advance payment for land, advance payment for building construction, and 100% advance payment for goods and services as inquired by the Stock Exchange of Thailand

Read the full announcement on the SET website ↗
29 May 2026

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026 (Revised)

Read the full announcement on the SET website ↗
15 May 2026

Financial Performance Quarter 1 (F45) (Reviewed)

Read the full announcement on the SET website ↗
15 May 2026

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026

Read the full announcement on the SET website ↗
15 May 2026

Financial Statement Quarter 1/2026 (Reviewed)

Read the full announcement on the SET website ↗
20 Apr 2026

Disclosure of Minutes of the Annual General Meeting of Shareholders for the year 2026 on the Company's website

Read the full announcement on the SET website ↗
10 Apr 2026

Notification of the resolutions of the Annual General Meeting of Shareholders for the year 2026

Read the full announcement on the SET website ↗
19 Mar 2026

Notification of the Publication of the 2026 Annual General Meeting of Shareholders Documents on the Company's Website

Read the full announcement on the SET website ↗
26 Feb 2026

Notification of Board Resolutions: Dividend Payment, Legal Reserve Allocation, Amendments to Objectives & MOA, Registered Capital Reduction, and Schedule for the 2026 Annual General Meeting of Shareholders (AGM)

Read the full announcement on the SET website ↗
26 Feb 2026

Report on the results of offering the right to propose Agenda and Nominees persons to be elected as Directors and submission questions in advances for to the 2026 Annual General Meeting of Shareholders.

Read the full announcement on the SET website ↗
26 Feb 2026

Financial Performance Yearly (F45) (Audited)

Read the full announcement on the SET website ↗
26 Feb 2026

Management Discussion and Analysis Yearly Ending 31 Dec 2025

Read the full announcement on the SET website ↗
26 Feb 2026

Financial Statement Yearly 2025 (Audited)

Read the full announcement on the SET website ↗
4 Feb 2026

Invitation to Shareholders to Propose Agenda Items, Nominate Candidates for Director Election, and Submit Questions in Advance for the 2026 Annual General Meeting of Shareholders

Read the full announcement on the SET website ↗
19 Dec 2025

Notification of the Change in the Shareholding Structure of the Company

Read the full announcement on the SET website ↗
11 Nov 2025

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025

Read the full announcement on the SET website ↗
11 Nov 2025

Financial Performance Quarter 3 (F45) (Reviewed)

Read the full announcement on the SET website ↗
11 Nov 2025

Financial Statement Quarter 3/2025 (Reviewed)

Read the full announcement on the SET website ↗
25 Sept 2025

Notification of Resignation from the Position of Chief Executive Officer (Acting) and Chairman of the Executive Committee (Acting), Appointment of Chief Executive Officer and Chairman of the Executive Committee

Read the full announcement on the SET website ↗